Navigation Links
Survived cancer? Now look out for cardiovascular risks
Date:4/16/2013

WINSTON-SALEM, N.C., April 16, 2013 Many people survive their cancers, but end up dying of cardiovascular disease (CVD). New research from Wake Forest Baptist Medical Center finds that CVD risk factors may be overlooked during survivorship care.

Kathryn E. Weaver, Ph.D., assistant professor of social sciences and health policy at Wake Forest Baptist, and colleagues surveyed survivors of breast, prostate, colorectal and gynecologic cancers in search of answers.

"Increasingly, we are concerned about cardiovascular health in long-term cancer survivors, and we believe this is a high-risk group that needs close attention," lead author Weaver said. "As part of good survivorship health, it's going to be increasingly important for health care providers to assess and address cardiovascular risk in cancer survivors."

For example, Weaver said there is data showing that early stage breast cancer patients are more likely to die of CVD than of breast cancer. There are many reasons why cancer survivors have higher CVD risks, she said, most typically because cancer shares many of the same risk factors such as smoking, low physical activity and obesity. Also, some of the treatments cancer patients undergo may put them at higher risk, she said.

The survey participants were recruited from two cancer registries. A total of 1,582 survivors who were four to 14 years beyond diagnosis were asked in a mail survey to assess CVD risk factors, including smoking, body mass index, physical inactivity, hypertension and diabetes. The researchers also asked the participants whether they had engaged in discussions with health care providers about making lifestyle changes through diet, exercise and quitting smoking.

With the exception of current smoking, CVD risk factors were more common among survivors than the general adult population. Of survivors, 62 percent were overweight or obese, 55 percent reported hypertension, 20.7 percent reported diabetes, 18.1 percent were inactive, and 5.1 percent were current smokers. Nearly a third of survivors with CVD risk factors did not report health-promotion discussions with their medical teams.

Weaver said they also saw significant differences for Hispanic and African-American survivors when compared to white survivors that are similar to those observed in adults without cancer. These two ethnic groups had a greater number of CVD risk factors, particularly obesity and diabetes.

"What we found is that cancer survivors do have more cardiovascular risk factors than the general adult population, and they often do not report talking with their health care provider about ways to reduce their risk through lifestyle changes like exercising and losing weight," Weaver said.

This study highlights the need for more awareness by cancer survivors and their doctors, Weaver said. "Our message is that cardiovascular disease risk should be assessed as part of a comprehensive survivorship care plan because of the risk for both poor heart disease and cancer outcomes," she said. "Cancer providers don't have to be solely responsible for talking to survivors about lifestyle factors, but, if it's noted as part of the wellness goals for that survivor, then risk factors are more likely to be addressed by the survivors' treatment team, including primary care."


'/>"/>

Contact: Bonnie Davis
bdavis@wakehealth.edu
336-716-4977
Wake Forest Baptist Medical Center
Source:Eurekalert

Related medicine news :

1. You Survived Cancer: Now Pay Attention to Your Overall Health
2. Vitamin D + TB vaccine: Allies in fight against bladder cancer?
3. Do Bald Men Face Higher Risk of Prostate Cancer?
4. Does More Dental Plaque Mean Higher Chances of Dying From Cancer?
5. Could Sunlight Lower Your Odds for Pancreatic Cancer?
6. Would sliding back to pre-PSA era cancel progress in prostate cancer?
7. How is grief unique to young adults with cancer?
8. How can evolutionary biology explain why we get cancer?
9. Is Early Baldness in Blacks a Clue to Prostate Cancer?
10. Can Selenium Lower Risk of Advanced Prostate Cancer?
11. Original research papers on acute cardiovascular care: ESC launches EHJ-ACVC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2017)... SALISBURY, MD. (PRWEB) , ... June 26, 2017 ... ... their crop, according to a recent review of government data released by the ... continuous improvement in management practices, Maryland’s soybean farmers have increased their productivity on ...
(Date:6/26/2017)... Tahoe, CA (PRWEB) , ... June 26, 2017 , ... ... 10,000 qualified mental health professionals in every state across the country to join its ... easy and rewarding way for therapists to reach a substantially greater number of people ...
(Date:6/26/2017)... Moscow, RU (PRWEB) , ... June 26, 2017 , ... ... released a whitepaper that pledges to solve many catastrophic issues within funding ... September 2017. , The typical notion of crowdfunding - the raising of funds through ...
(Date:6/25/2017)... , ... June 25, 2017 , ... FCPX LUT Vintage ... an old-fashioned vintage look. FCPX LUT Vintage Volume 2 contains 60 different color-grade presets, ... for distorted looks, vignettes and blurs to single out subjects, plus much more. FCPX ...
(Date:6/25/2017)... ... 2017 , ... Republicans in the United States Senate on Thursday released their ... Reconciliation Act. It differs significantly from the American Health Care Act, which the House ... or the House will have to take up the Senate version as-is, if it ...
Breaking Medicine News(10 mins):
(Date:6/16/2017)...  Exactly 50 years ago today, the Monterey Pop Festival ... as the San Francisco "Summer of Love."  To celebrate the ... innovations in strategic market research portals that it will begin ... of Northern Light,s "Summer of Love (For Our Customers)."  ... ...
(Date:6/14/2017)...  In 2016, Embodied Labs took top ... and came away with $25,000 in seed-fund investment. Embodied ... as "entering the life of another" and by the ... to medical professionals in an entirely new dimension." Building ... finalist for the Department of Education,s EdSimChallenge, where they ...
(Date:6/11/2017)... , June 10, 2017  Eli Lilly and Company (NYSE: ... three Phase 3 studies of galcanezumab, an investigational treatment ... late-breaking data on several key secondary endpoints for galcanezumab ... from these studies (EVOLVE-1, EVOLVE-2 and REGAIN) will be ... scientific meeting in Boston . ...
Breaking Medicine Technology: